Bellis perennis
Bellis perennis is an FDA drug label for the active ingredient BELLIS PERENNIS manufactured by Boiron administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20231109.
Generic: BELLIS PERENNIS
Manufacturer: Boiron
Product Type: HUMAN OTC DRUG
Route: ORAL
Dosage Form:
NDC: 0220-0734
Application:
Effective: 20231109
Active Ingredients: Bellis perennis 1M (**contains 0.443 mg of the active ingredient per pellet)
Indications & Usage
Post-traumatic breast pain*
Dosage & Administration
Adults and children: At the onset of symptoms, dissolve 5 pellets under the tongue 3 times a day until symptoms are relieved or as directed by a doctor.
Contraindications
Not available.
Warnings
Not available.
Adverse Reactions
Not available.
More from same ingredient
BELLIS PERENNIS
Rxhomeo Private Limited d.b.a. Rxhomeo, Inc
Bellis Perennis
Hahnemann Laboratories, INC.
Bellis Perennis
OHM PHARMA INC.